Compare ALC & ROP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALC | ROP |
|---|---|---|
| Founded | 1945 | 1981 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.9B | 35.1B |
| IPO Year | 2002 | 2002 |
| Metric | ALC | ROP |
|---|---|---|
| Price | $75.83 | $352.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 18 |
| Target Price | $89.38 | ★ $492.60 |
| AVG Volume (30 Days) | ★ 1.3M | 1.1M |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | 0.24% | ★ 1.03% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 14.20 |
| Revenue | N/A | ★ $7,902,500,000.00 |
| Revenue This Year | $7.99 | $8.80 |
| Revenue Next Year | $6.38 | $6.73 |
| P/E Ratio | $38.31 | ★ $24.93 |
| Revenue Growth | N/A | ★ 12.26 |
| 52 Week Low | $71.55 | $313.07 |
| 52 Week High | $99.20 | $584.03 |
| Indicator | ALC | ROP |
|---|---|---|
| Relative Strength Index (RSI) | 43.18 | 46.13 |
| Support Level | $72.49 | $343.13 |
| Resistance Level | $76.99 | $364.24 |
| Average True Range (ATR) | 1.45 | 9.35 |
| MACD | -0.20 | -0.08 |
| Stochastic Oscillator | 9.70 | 25.60 |
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
Roper Technologies is a holding company focused on acquiring, managing, and developing niche market-leading technology businesses. The company operates a decentralized business model whereby each portfolio company operates independently from the others. Roper positions itself as a free cash flow compounder, whereby excess free cash flow generated by its portfolio businesses is repatriated to the parent company, which is then utilized to acquire additional businesses. Presently, the company operates 30 distinct businesses with over three-fourths of the revenue coming from software products and over two-thirds of the revenue coming from recurring and recurring sources.